Senegal has a high rate of tuberculosis and a low HIV seropositivity rate and aspergilloma,
life-threatening fungal infections, dermatophytosis and mycetoma have been
reported in this study. All published epidemiology papers reporting fungal infection
rates from Senegal were identified. Where no data existed, we used specific populations
at risk and fungal infection frequencies in each to estimate national incidence
or prevalence. The results show that tinea capitis is common being found in 25% of
children, ~1.5 million. About 191 000 Senegalese women get recurrent vaginal
thrush, =4 times annually. We estimate 685 incident cases of chronic pulmonary
aspergillosis (CPA) following TB and prevalence of 2160 cases. Asthma prevalence
in adults varies from 3.2% to 8.2% (mean 5%); 9976 adults have allergic bronchopulmonary
aspergillosis (ABPA) and 13 168 have severe asthma with fungal
sensitisation (SAFS). Of the 59 000 estimated HIV-positive patients, 366 develop
cryptococcal meningitis; 1149 develop Pneumocystis pneumonia and 1946 develop
oesophageal candidiasis, in which oral candidiasis (53%) and dermatophytosis (16%)
are common. Since 2008–2010, 113 cases of mycetoma were diagnosed. In conclusion,
we estimate that 1 743 507 (12.5%) people in Senegal suffer from a fungal
infection, excluding oral candidiasis, fungal keratitis, invasive candidiasis or
aspergillosis. Diagnostic and treatment deficiencies should be rectified to allow epidemiological
studies.